Global Sulfasalazine Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Sulfasalazine Market Research Report 2024
Sulfasalazine is a sulfanilamide antibiotic.It is an oral sulfonamide drug that is not easy to be absorbed. The absorbed part is decomposed into 5-amino salicylic acid and sulfonamide pyridine under the action of intestinal microorganisms.5-aminosalicylic acid stays in the intestinal wall for a long time after complexing with the connective tissue of the intestinal wall, which plays an antibacterial and anti-inflammatory role and plays an immunosuppressive role, such as reducing escherichia coli and clostridium difficile, and inhibiting the synthesis of prostaglanin and other inflammatory mediators, leukotrienes.Therefore, it is believed that the main component of this product is 5-aminosalicylic acid.Sulfamopyridine produced by the decomposition of this product showed weak antibacterial effect on intestinal flora.
According to Mr Accuracy reports’s new survey, global Sulfasalazine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sulfasalazine market research.
Key manufacturers engaged in the Sulfasalazine industry include Crescent Pharma Limited, Pfizer, Saaz-DS, KRKA, Vintage, Qualitest, NPS Medicinewise, Kamp Medicine and Hubei Wudang, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Sulfasalazine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Sulfasalazine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sulfasalazine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Crescent Pharma Limited
Pfizer
Saaz-DS
KRKA
Vintage
Qualitest
NPS Medicinewise
Kamp Medicine
Hubei Wudang
Hebei Yinengpu
Shanxi Wanshou
Fujian Fukang
Guangzhou Huahai
WATSON LABS
Pharmacia & Upjohn
Chongqing Dikang
Shanghai Xinyi Tianping Pharmaceutical
Segment by Type
Enteric Sugar Coated Tablet
Film-Coated Tablet
Other
Crohn's Disease
Ulcerative Colitis (Chronic Nonspecific Ulcerative Colitis)
Ankylosing Spondylitis
Other
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Sulfasalazine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Sulfasalazine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sulfasalazine market research.
Key manufacturers engaged in the Sulfasalazine industry include Crescent Pharma Limited, Pfizer, Saaz-DS, KRKA, Vintage, Qualitest, NPS Medicinewise, Kamp Medicine and Hubei Wudang, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Sulfasalazine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Sulfasalazine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sulfasalazine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Crescent Pharma Limited
Pfizer
Saaz-DS
KRKA
Vintage
Qualitest
NPS Medicinewise
Kamp Medicine
Hubei Wudang
Hebei Yinengpu
Shanxi Wanshou
Fujian Fukang
Guangzhou Huahai
WATSON LABS
Pharmacia & Upjohn
Chongqing Dikang
Shanghai Xinyi Tianping Pharmaceutical
Segment by Type
Enteric Sugar Coated Tablet
Film-Coated Tablet
Other
Segment by Application
Crohn's Disease
Ulcerative Colitis (Chronic Nonspecific Ulcerative Colitis)
Ankylosing Spondylitis
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Sulfasalazine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source